Propofol sedation produces dose-dependent suppression of lidocaine-induced seizures in rats

• Published in: Anesthesia and analgesia Vol. 86; no. 3; pp. 652 - 657
• Main Authors: LEE, V. C, MOSCICKI, E. C, DIFAZIO, C. A
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott 01.03.1998
• Subjects: Anesthetics, Local; Animals; Biological and medical sciences; Carbon Dioxide - blood; Dose-Response Relationship, Drug; Drug toxicity and drugs side effects treatment; Heart Rate - drug effects; Hydrogen-Ion Concentration; Hypnotics and Sedatives - pharmacology; Lidocaine; Male; Medical sciences; Oxygen - blood; Pharmacology. Drug treatments; Propofol - pharmacology; Rats; Rats, Sprague-Dawley; Respiration - drug effects; Seizures - chemically induced; Toxicity: nervous system and muscle; Rat; Toxicity; Rodentia; Sedation; Local anesthetic; Prevention; Vertebrata; Mammalia; Regional anesthesia; Convulsion; Animal; Propofol; Sedative; Neurological disorder; Lidocaine
• ISSN: 0003-2999; 1526-7598
• DOI: 10.1097/00000539-199803000-00040

The association of propofol with excitatory motor activity, such as myoclonic jerking and opisthotonus, in humans and in animals suggests that it may aggravate clinical seizure activity in some circumstances, although evidence suggests that under other circumstances, propofol inhibits seizure activity. In the current study, we assessed the effect of sedating doses of propofol on lidocaine-induced seizure activity in spontaneously breathing rats receiving no other anesthetics. Adult Sprague-Dawley male rats, 300-400 g, were divided into a control group and three experimental groups representing three graded levels of propofol sedation. The control rats then received a lidocaine infusion at the rate of 150 mg x kg(-1) x h(-1), resulting in a slow, progressive increase in systemic lidocaine concentrations. At the onset of electroencephalographic (EEG) seizure activity, arterial lidocaine concentrations were obtained. The treated rats received propofol according to three different dose schedules: Dose 1 = 10 mg x kg(-1) x h(-1) after a 2.5-mg/kg bolus; Dose 2 = 20 mg x kg(-1) x h(-1) after a 5-mg/kg bolus; Dose 3 = 40 mg x kg(-1) x h(-1) after a 10-mg/kg bolus. After 30 min, a steady level of sedation, dependent on the dose of propofol, was achieved. The lidocaine infusion was then started, and systemic lidocaine levels were obtained at the onset of EEG seizure activity. The lidocaine was continued until the onset of death by cardiac arrest. Plasma lidocaine was measured by gas chromatography. Analysis of variance and Dunnett's t-test were used for comparisons with the control values. Continuous propofol sedation increased the seizure dose of lidocaine from 37.7 +/- 3.5 mg/kg (mean +/- SEM) to 52.5 +/- 2.6 mg/kg (Dose 1, P < 0.05) and 67.9 +/- 8.6 mg/kg (Dose 2, P < 0.05), and completely abolished lidocaine seizures at Dose 3. The lethal dose of lidocaine, 89.4 +/- 10.5 mg/kg control versus 108.7 +/- 10.3 mg/kg (Dose 1), 98.3 +/- 10.1 mg/kg (Dose 2), and 93.5 +/- 10.4 mg/kg (Dose 3) did not differ among groups. The lidocaine levels at seizure threshold were increased in the propofol-treated rats: 16.9 +/- 0.5 microg/mL control versus 19.2 +/- 0.7 microg/mL (Dose 1, P = not significant) and 23.7 +/- 1.8 microg/mL (Dose 2, P < 0.05). Continuous propofol sedation in spontaneously breathing rats receiving no other anesthetics exerts a protective effect against lidocaine-induced seizures in a monotonic, dose-dependent fashion. The cardiac arrest dose of lidocaine is unaffected by propofol under these conditions. The i.v. anesthetic drug propofol, given to rats to produce sedation, was found to suppress seizure activity caused by overdosage of the local anesthetic lidocaine.